Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2018-07-09 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
2017年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2017 annual equity distribution plan by 三诺生物传感股份有限公司. It details the dividend payment per share, the stock dividend, the record date, ex-dividend date, and the shareholders entitled to the distribution. It also includes information on share capital changes and dividend tax policies. The document is relatively short (3075 characters) and focuses on the dividend distribution details rather than presenting a full financial report or annual report. This matches the description of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2018-07-09 Chinese
独立董事关于公司第三届董事会第二十四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on a specific board meeting matter regarding the cancellation of reserved restricted stock grants. It references compliance with regulatory guidelines and company bylaws, and it is signed by independent directors. The content is focused on board/management decisions rather than financial results, audit, or shareholder voting outcomes. The document length is short (920 characters), and it is not a report or announcement of a report but an opinion related to board decisions. Therefore, it fits best under Board/Management Information (MANG).
2018-06-22 Chinese
关于取消授予预留限制性股票的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from a company regarding the cancellation of the grant of reserved restricted shares under a 2017 restricted stock incentive plan. It details board and supervisory meetings, legal opinions, and the rationale for the cancellation of 540,000 reserved restricted shares. The content focuses on corporate governance and management decisions related to stock incentives, not on financial results, earnings, or annual reporting. It is not a full report but an announcement of a corporate action related to management and board decisions. Therefore, the document fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management.
2018-06-22 Chinese
第三届监事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution passed at the 18th meeting of the third Supervisory Board of SanNuo Biological Sensor Co., Ltd. It details the meeting attendance, the agenda, and the voting results regarding the cancellation of reserved restricted stock grants. The document is short (1049 characters) and serves as a formal announcement of a board/committee decision rather than a full report or financial statement. It does not contain financial data or detailed management discussion, nor is it a regulatory filing or certification. The content fits best under Board/Management Information (MANG) as it relates to decisions made by the supervisory board, which is part of company management oversight.
2018-06-22 Chinese
第三届董事会第二十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 24th meeting of the third board of directors of SanNuo Biological Sensor Co., Ltd. It details the meeting date, attendance, agenda, and voting results, specifically about canceling the grant of reserved restricted shares. There is no financial data, no detailed report or presentation, and no mention of annual or quarterly results. The document is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1104 characters), and it is not an announcement of a report publication but a direct announcement of board decisions. Therefore, the classification is MANG with high confidence.
2018-06-22 Chinese
北京国枫律师事务所关于公司2017年限制性股票激励计划取消授予预留限制性股票相关事项的法律意见书
Regulatory Filings
2018-06-22 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.